Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TRC101 in Subjects With Chronic Kidney Disease and Metabolic Acidosis

NCT03317444 is registered in ClinicalTrials.gov with Tricida, Inc. as lead sponsor.

NCT NCT03317444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03317444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TRC101 in Subjects With Chronic Kidney Disease and Metabolic Acidosis
Lead sponsor
Tricida, Inc.
Phase
Phase 3
Overall status
Completed
Start date
September 26, 2017
Completion date
May 15, 2018
Enrollment
217 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic acidosis